{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:54:38Z","timestamp":1790736878323,"version":"4.1.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1001\/jamaneurol.2019.0250","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T12:01:03Z","timestamp":1552910463000},"page":"710","source":"Crossref","is-referenced-by-count":59,"title":["Association of\n                    <i>MAPT<\/i>\n                    Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology"],"prefix":"10.1001","volume":"76","author":[{"given":"Michael G.","family":"Heckman","sequence":"first","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca R.","family":"Brennan","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Labb\u00e9","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra I.","family":"Soto","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"DeTure","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley F.","family":"Boeve","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"van Gerpen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Uitti","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rademakers","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"},{"name":"Department of Clinical Genomics, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"noi190008r1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria.","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"issue":"4","key":"noi190008r2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy.","volume":"23","author":"Dickson","year":"2010","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"noi190008r3","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/(ISSN)1531-8257","article-title":"Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank.","volume":"18","author":"Josephs","year":"2003","journal-title":"Mov Disord"},{"issue":"7","key":"noi190008r4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol"},{"issue":"10","key":"noi190008r5","doi-asserted-by":"publisher","first-page":"24629","DOI":"10.3390\/ijms161024629","article-title":"Genetics underlying atypical parkinsonism and related neurodegenerative disorders.","volume":"16","author":"Scholz","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"2","key":"noi190008r6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1508","article-title":"A common inversion under selection in Europeans.","volume":"37","author":"Stefansson","year":"2005","journal-title":"Nat Genet"},{"issue":"2","key":"noi190008r7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Genetic evidence for the involvement of tau in progressive supranuclear palsy.","volume":"41","author":"Conrad","year":"1997","journal-title":"Ann Neurol"},{"issue":"4","key":"noi190008r8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/hmg\/8.4.711","article-title":"Association of an extended haplotype in the tau gene with progressive supranuclear palsy.","volume":"8","author":"Baker","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"2","key":"noi190008r9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.","volume":"56","author":"Pastor","year":"2004","journal-title":"Ann Neurol"},{"issue":"21","key":"noi190008r10","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1093\/hmg\/ddi361","article-title":"High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.","volume":"14","author":"Rademakers","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"11","key":"noi190008r11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/jmg.2005.031377","article-title":"Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.","volume":"42","author":"Pittman","year":"2005","journal-title":"J Med Genet"},{"issue":"4","key":"noi190008r12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1086\/513320","article-title":"Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.","volume":"80","author":"Melquist","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"7","key":"noi190008r13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","article-title":"Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.","volume":"43","author":"H\u00f6glinger","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"noi190008r14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jalz.2016.05.002","article-title":"MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.","volume":"12","author":"Labb\u00e9","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"3","key":"noi190008r15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/archneurol.2011.17","article-title":"Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.","volume":"68","author":"Set\u00f3-Salvia","year":"2011","journal-title":"Arch Neurol"},{"key":"noi190008r16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2016.06.010","article-title":"MAPT haplotype diversity in multiple system atrophy.","volume":"30","author":"Labb\u00e9","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"noi190008r17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1212\/WNL.57.1.138","article-title":"Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy.","volume":"57","author":"Litvan","year":"2001","journal-title":"Neurology"},{"issue":"1-2","key":"noi190008r18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2006.06.032","article-title":"Effect of MAPT and APOE on prognosis of progressive supranuclear palsy.","volume":"405","author":"Baba","year":"2006","journal-title":"Neurosci Lett"},{"issue":"2","key":"noi190008r19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.nbd.2008.09.027","article-title":"5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.","volume":"33","author":"Cruchaga","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"2","key":"noi190008r20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00401-016-1576-7","article-title":"Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.","volume":"132","author":"Allen","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"12","key":"noi190008r21","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/mds.27196","article-title":"Genetic influences on cognition in progressive supranuclear palsy.","volume":"32","author":"Gerstenecker","year":"2017","journal-title":"Mov Disord"},{"issue":"11","key":"noi190008r22","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","article-title":"Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).","volume":"44","author":"Hauw","year":"1994","journal-title":"Neurology"},{"issue":"8","key":"noi190008r23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.parkreldis.2013.03.005","article-title":"Investigating the role of FUS exonic variants in essential tremor.","volume":"19","author":"Labb\u00e9","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"noi190008r24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/alzrt268","article-title":"Association of MAPT haplotypes with Alzheimer\u2019s disease risk and MAPT brain gene expression levels.","volume":"6","author":"Allen","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"noi190008r26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"12","key":"noi190008r27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD.","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"pt 5","key":"noi190008r28","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050","article-title":"Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum.","volume":"138","author":"Murray","year":"2015","journal-title":"Brain"},{"issue":"2","key":"noi190008r29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1086\/338688","article-title":"Score tests for association between traits and haplotypes when linkage phase is ambiguous.","volume":"70","author":"Schaid","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"16","key":"noi190008r30","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/hmg\/ddi241","article-title":"The H1c haplotype at the MAPT locus is associated with Alzheimer\u2019s disease.","volume":"14","author":"Myers","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"3","key":"noi190008r31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.nbd.2006.10.018","article-title":"The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.","volume":"25","author":"Myers","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"9","key":"noi190008r32","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.neurobiolaging.2007.11.019","article-title":"Association of MAPT haplotype-tagging SNPs with sporadic Parkinson\u2019s disease.","volume":"30","author":"Vandrovcova","year":"2009","journal-title":"Neurobiol Aging"},{"key":"noi190008r25","author":"Dickson"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/6\/710\/17656789\/jamaneurology_heckman_2019_oi_190008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:01:04Z","timestamp":1560164464000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2019.0250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.0250","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}